Armata Pharmaceuticals (ARMP)
(Real Time Quote from BATS)
$2.57 USD
-0.14 (-5.17%)
Updated Aug 5, 2025 03:34 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ARMP 2.57 -0.14(-5.17%)
Will ARMP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARMP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARMP
ARMP Soars 72% in a Month Following Infectious Disease Study Success
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
ARMP: What are Zacks experts saying now?
Zacks Private Portfolio Services
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates
New Strong Sell Stocks for May 8th
Other News for ARMP
Armata Pharmaceuticals Elects Board Members at Annual Meeting
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma
Armata Pharmaceuticals (ARMP) Experiences Massive Surge in Interest | ARMP Stock News
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today